Sofi Vikström
YOU?
Author Swipe
View article: Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort study
Loss in life expectancy in patients with stage II-III cutaneous melanoma in Sweden: A population-based cohort study Open
Our results are both clinically relevant and easy-to-interpret measures of the impact of CM on survival, but the results also summarize the prognosis over the lifetime of a CM patient.
View article: Increasing melanoma incidence and survival trend shifts with improved melanoma-specific survival between 1990 and 2020 in Sweden
Increasing melanoma incidence and survival trend shifts with improved melanoma-specific survival between 1990 and 2020 in Sweden Open
Background Melanoma-specific survival (MSS) is heterogenous between stages and is highly dependent on the T stage for primary localized disease. New systemic therapies for metastatic cutaneous melanoma (CM) have been introduced since 2012 …